KMPH
KemPharm Inc
Price:  
5.81 
USD
Volume:  
64,126.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KMPH WACC - Weighted Average Cost of Capital

The WACC of KemPharm Inc (KMPH) is 38.1%.

The Cost of Equity of KemPharm Inc (KMPH) is 8.05%.
The Cost of Debt of KemPharm Inc (KMPH) is 385.70%.

Range Selected
Cost of equity 6.90% - 9.20% 8.05%
Tax rate 0.40% - 0.70% 0.55%
Cost of debt 7.00% - 764.40% 385.70%
WACC 6.9% - 69.3% 38.1%
WACC

KMPH WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.54 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.20%
Tax rate 0.40% 0.70%
Debt/Equity ratio 0.09 0.09
Cost of debt 7.00% 764.40%
After-tax WACC 6.9% 69.3%
Selected WACC 38.1%